MedTrace Logo

Communication Bridge Pilot Study

NCT06211374 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2025-08-07

No results posted yet for this study

Summary

The aim of this study is to evaluate the effectiveness and feasibility of evidence-based interventions in individuals living with mild to moderate primary progressive aphasia (PPA) that address communication-focused outcomes.

Conditions

  • Primary Progressive Aphasia

Interventions

BEHAVIORAL

Communication Bridge

Evidence-based speech language therapy treatment will be compared and contrasted in the two arms of the study.

Sponsors & Collaborators

  • Western University, Canada

    collaborator OTHER

  • National Institute on Aging (NIA)

    collaborator NIH

  • University of Chicago

    lead OTHER

Principal Investigators

  • Emily Roglaski, PhD · Professor of Neurology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-28
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06211374 on ClinicalTrials.gov